SCHEMBL29332770

SCHEMBL29332770

Cc1c(-c2ccccc2O)cc(-c2ccc(F)cc2)[nH]c1=N

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 2/20 0.46
▸ NPC1 O15118 2/20 0.46
▸ KMT2A Q03164 2/20 0.46
▸ GSK3B P49841 1/20 0.40
▸ GCGR P47871 3/20 0.39
▸ MAPK14 Q16539 3/20 0.39
▸ ALOX5 P09917 1/20 0.38
▸ ERCC1 P07992 1/20 0.37
▸ ERCC4 Q92889 1/20 0.37
▸ CTSV O60911 1/20 0.37
▸ CTSL P07711 1/20 0.37
▸ MAPK1 P28482 3/20 0.36
▸ MAPT P10636 2/20 0.36
▸ KDM4E B2RXH2 2/20 0.36
▸ L3MBTL1 Q9Y468 2/20 0.36
▸ ALOX15 P16050 2/20 0.36
▸ LMNA P02545 2/20 0.36
▸ TP53 P04637 1/20 0.36
▸ ALOX12 P18054 1/20 0.36
▸ NFKB1 P19838 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29331889 0.81 MEN1 (0.43) MEN1NPC1KMT2AGSK3BGCGR
SCHEMBL23920029 0.81 PIM1 (0.47) MEN1NPC1KMT2AGCGRMAPK14
SCHEMBL29332771 0.68 GSK3B (0.55) MEN1NPC1KMT2AGSK3BMAPT
SCHEMBL10993289 0.68 ALDH1A1 (0.65) MEN1NPC1KMT2AALOX5MAPT
SCHEMBL28779247 0.67 ALDH1A1 (0.58) MEN1NPC1KMT2AALOX5MAPT
SCHEMBL10357523 0.66 MEN1 (0.78) MEN1NPC1KMT2AMAPK1MAPT
SCHEMBL31695313 0.66 IL4 (0.54) MEN1KMT2AGSK3BGCGRMAPK14
SCHEMBL23841138 0.66 ATM (0.57) MEN1KMT2AGCGRMAPK14MAPT
SCHEMBL16055422 0.66 TRPA1 (0.45) MEN1NPC1KMT2AGSK3BMAPK14
Fluorobenzene SCHEMBL28353608 0.64 ALDH1A1 (0.64) MEN1NPC1KMT2AALOX5MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12043621-B2 Small molecule inhibitors of Interleukin-4 TRUSTEES OF BOSTON UNIVERSITY (US) 2024-07-23 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12043621-B2 Small molecule inhibitors of Interleukin-4 IL4, IL2, IL4I1 MEN1 3952/4885NPC1 4117/4885KMT2A 2798/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback